Overview

One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This purpose of this study is to evaluate the long-term safety and tolerability of azilsartan medoxomil in individuals with essential hypertension.
Phase:
Phase 3
Details
Lead Sponsor:
Takeda
Treatments:
Azilsartan medoxomil
Chlorthalidone
Hydrochlorothiazide